- Home
- AFCG vs TIL Comparison
AFCG vs TIL Comparison
Compare AFCG & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AFCG | TIL |
|---|---|---|
| Founded | 2020 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.4M | 52.2M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AFCG | TIL |
|---|---|---|
| Price | $3.57 | $7.58 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 3 |
| Target Price | $4.50 | ★ $125.00 |
| AVG Volume (30 Days) | ★ 104.9K | 5.8K |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | ★ 6.94% | N/A |
| EPS Growth | N/A | ★ 6.06 |
| EPS | ★ 0.72 | N/A |
| Revenue | ★ $24,563,601.00 | N/A |
| Revenue This Year | $1,334.03 | N/A |
| Revenue Next Year | $17.33 | N/A |
| P/E Ratio | $4.97 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.06 | $5.67 |
| 52 Week High | $4.69 | $30.50 |
Technical Indicators
Market Signals| Indicator | AFCG | TIL |
|---|---|---|
| Relative Strength Index (RSI) | 64.63 | 51.76 |
| Support Level | $2.75 | $7.43 |
| Resistance Level | $3.84 | $7.99 |
| Average True Range (ATR) | 0.18 | 0.22 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 78.00 | 48.21 |
Price Performance
Historical ComparisonAbout AFCG AFC Gamma Inc.
Advanced Flower Capital Inc is an externally managed Maryland corporation that operates as a Business Development Company (BDC). The firm's primary operations involve originating, structuring, underwriting, and managing senior secured loans and other debt securities. Its investment portfolio includes loans to state law-compliant cannabis operators, ancillary cannabis businesses, and middle-market companies in other industries. These loans are typically secured by collateral such as real estate, equipment, cash flows, and license values.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.